Delivery Order SPE2DB20D3103-SPE2DB26FL4A4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Envarsus XR 1 mg tablets (100 count) with a ceiling value of $1,288.86. This firm fixed-price delivery order, which must be completed by November 7, 2025, represents a non-set-aside, competitively awarded contract. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages) with a contract ceiling value of $1,711.95. This firm fixed-price delivery order, which has an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100s, with a ceiling value of $1,718.48 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,718.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is expected to be completed by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,718.48 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $1,553.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Envarsus XR 0.75 mg tablets (30-count) with a contract ceiling value of $1,169.76. This is a firm fixed-price delivery order without a set-aside designation, issued under competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Envarsus XR 1 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,718.48 and is scheduled for completion by September 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action under a larger vehicle, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages) under a firm fixed-price contract valued at $5,135.85, with completion scheduled for October 20, 2025. The contract was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4A4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Envarsus XR 1 mg tablets (100-count packages) with a ceiling value of $2,495.18. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies across the Defense Health System. The parent IDC contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a broad range of medications, including specialty drugs, generics, vaccines, and medical supplies to military healthcare programs worldwide. The delivery order for Envarsus XR, an immunosuppressant medication used in transplant patients, exemplifies the company's role in supporting military beneficiary healthcare needs through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/27/25 |